Brind.

New Haven-based biotech Yarrow Bioscience was acquired by Johnson & Johnson for $3.05 billion in 2025.

1 report, 1 independent Updated Aug 14

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

New Haven Johnson & Johnson

Keep exploring

The entities involved

New Haven
city in Connecticut, United States
- Coastal flooding is possible in Fairfield and New Haven counties, while Middlesex counties face high wind warnings.Sun 02:06
- Yale economists in New Haven are studying Connecticut's state policies.Fri 16:46
Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04

Related events

Coverage

Newest first; wire copies grouped

Aug 14hartfordbusiness.com